Sunnyvale, CA, United States of America

Angiotrax, Inc.


USPTO Granted Patents = 15

Forward Citations = 8,268

Loading Chart...
Loading Chart...

8 inventors (with patents filed for the assignee):

goldMedal Vahid Saadat (15 out of 23 patents)

silverMedal John H Ream (5 out of 14 patents)

bronzeMedal Joseph M Tartaglia (2 out of 33 patents)

4.  Susan Philip (2 out of 2 patents)

5.  Peter K Park (2 out of 6 patents)

6.  Eric W Leopold (2 out of 42 patents)

7.  John A Macoviak (1 out of 52 patents)

8.  James Kermode (1 out of 1 patent)


15 patents:

Angiotrax, Inc. is a biotechnology company based in Sunnyvale, California, specializing in the development of innovative therapies targeting vascular diseases. The organization focuses on leveraging advanced research in molecular biology and pharmacology to create solutions that address critical unmet medical needs in the treatment of conditions related to blood vessel dysfunction. With a commitment to scientific excellence, Angiotrax aims to improve patient outcomes through its cutting-edge therapeutic approaches.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

15 Patents

#229 in Sunnyvale, CA

#5,022 in California

#21,034 in US

#39,881 in the World

Sunnyvale, CA (US)
Sunnyvale, CA, United States of America
Forward Citations = 8,268

8 inventors:

Please report any incorrect information to [email protected]
Loading…